Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity-Reference-Cited by-同舟云学术

Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity

Published:2015-05-29 Issue:5 Volume:10 Page:e0124878
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Metushi Imir G.,Wriston Amanda,Banerjee Priyanka,Gohlke Bjoern Oliver,English A. Michelle,Lucas Andrew,Moore Carrie,Sidney John,Buus Soren,Ostrov David A.,Mallal Simon,Phillips Elizabeth,Shabanowitz Jeffrey,Hunt Donald F.,Preissner Robert,Peters Bjoern

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. HLA and pharmacogenetics of drug hypersensitivity;R Pavlos;Pharmacogenomics,2012

2. The structural basis of HLA-associated drug hypersensitivity syndromes;YA Pompeu;Immunol Rev,2012

3. HLA-B*5701 screening for hypersensitivity to abacavir;S Mallal;N Engl J Med,2008

4. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire;DA Ostrov;Proc Natl Acad Sci U S A,2012

5. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity;MA Norcross;AIDS,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations Toward Immunopeptidomics;Molecular & Cellular Proteomics;2024-09

2. Repurposing Cardio-Metabolic Drugs to Fight Covid19;High Blood Pressure & Cardiovascular Prevention;2021-09

3. Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2;Frontiers in Chemistry;2020-12-23

4. Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions;Journal of Interferon & Cytokine Research;2020-04-01

5. Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking;Journal of Cheminformatics;2018-01-30